Egor N. Grebenkin
Egor N. Grebenkin has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Uglesha Stanoyevich
Kursk State Medical University, Ministry of Health of Russia; G.E. Ostroverkhov Kursk Cancer Research and Clinical Center
3 shared publications - Alexandr N. Perepelevskiy
Ostroverkhov Kursk Oncology Research Clinical Center
2 shared publications - G. G. Akhaladze
Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation
2 shared publications - O. A. Ivanova
Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation
2 shared publications - Sergey V. Goncharov
Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation
2 shared publications - Vladimir A. Solodkiy
Russian Scientific Center of Roentgenoradiology
2 shared publications
Latest Publications
- 23 April 2024
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 13 (3)
Morphological and molecular genetic features of gastric cancer
High incidence, poor prognosis, risk of progression after radical surgical treatment, cellular and molecular genetic heterogeneity of gastric cancer represent a serious health problem worldwide; the annual death rate is more than 700.000 cases. Understanding oncogenesis, risk factors, and the use of new approaches to treating this pathology are priority tasks of modern oncology. This review is devoted to modern ideas about carcinogenesis, assessment of the morphologically unchanged gastric mucosa through the prism of the precancerous Correa cascade. The basic molecular mechanisms and signaling pathways of carcinogenesis are described, and the tumor microenvironment is characterized.
- 23 April 2024
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 13 (3)
Morphological and molecular genetic features of gastric cancer
High incidence, poor prognosis, risk of progression after radical surgical treatment, cellular and molecular genetic heterogeneity of gastric cancer represent a serious health problem worldwide; the annual death rate is more than 700.000 cases. Understanding oncogenesis, risk factors, and the use of new approaches to treating this pathology are priority tasks of modern oncology. This review is devoted to modern ideas about carcinogenesis, assessment of the morphologically unchanged gastric mucosa through the prism of the precancerous Correa cascade. The basic molecular mechanisms and signaling pathways of carcinogenesis are described, and the tumor microenvironment is characterized.
- Open Access
- 16 November 2023
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 22 (5) , 161-172
Takotsubo cardiomyopathy in locally advanced rectosigmoid junction cancer: a case report
Background. takotsubo cardiomyopathy (tcm) occurs more frequently in cancer patients than in the general population. The triggers for tcm in cancer patients include not only the inflammatory state of the cancer itself, but also the significant emotional stress of a cancer diagnosis and the physical stress associated with invasive diagnostic and treatment procedures.Case presentation. We describe the case of a 54-yearold woman with histologically verified rectosigmoid junction cancer (cT4bcN2M0) complicated by acute intestinal obstruction. In the early postoperative period, a sudden drop in blood pressure, t-wave inversion and Qt-interval prolongation on ecg, decrease in the left ventricle contractility and presence of wall motion abnormalities on echocardiography (ecHo), as well as an increase in biomarkers of myocardial damage were initially regarded as acute coronary syndrome, which was subsequently excluded according to the findings of coronary angiography, which did not reveal coronary artery obstruction. taking into account the rapid and complete inverse dynamics of changes, acute myocardial infarction without coronary artery obstruction and acute myocarditis were excluded. Ultimately, the diagnosis of takotsubo cardiomyopathy was established.Conclusion. this case report indicates that cancer can be a trigger for the development of tcm; therefore, the assessment of cardiological status and timely detection of cardiac complications in cancer patients during cancer treatment is extremely important and is aimed at increasing the overall survival in this category of patients.
- 16 November 2023
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 22 (5) , 161-172
Open AccessTakotsubo cardiomyopathy in locally advanced rectosigmoid junction cancer: a case report
Background. takotsubo cardiomyopathy (tcm) occurs more frequently in cancer patients than in the general population. The triggers for tcm in cancer patients include not only the inflammatory state of the cancer itself, but also the significant emotional stress of a cancer diagnosis and the physical stress associated with invasive diagnostic and treatment procedures.Case presentation. We describe the case of a 54-yearold woman with histologically verified rectosigmoid junction cancer (cT4bcN2M0) complicated by acute intestinal obstruction. In the early postoperative period, a sudden drop in blood pressure, t-wave inversion and Qt-interval prolongation on ecg, decrease in the left ventricle contractility and presence of wall motion abnormalities on echocardiography (ecHo), as well as an increase in biomarkers of myocardial damage were initially regarded as acute coronary syndrome, which was subsequently excluded according to the findings of coronary angiography, which did not reveal coronary artery obstruction. taking into account the rapid and complete inverse dynamics of changes, acute myocardial infarction without coronary artery obstruction and acute myocarditis were excluded. Ultimately, the diagnosis of takotsubo cardiomyopathy was established.Conclusion. this case report indicates that cancer can be a trigger for the development of tcm; therefore, the assessment of cardiological status and timely detection of cardiac complications in cancer patients during cancer treatment is extremely important and is aimed at increasing the overall survival in this category of patients.
- Open Access
- 15 December 2022
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 27 (4) , 57-70
Comparison of laparoscopic and open simultaneous surgeries for synchronous metastases of colorectal cancer in the liver: meta-analysis
Aim. To analyze studies focused on comparing laparoscopic and open simultaneous surgeries for synchronous metastases of colorectal cancer in the liver.Materials and methods. The electronic databases PubMed, Web of Science, Scopus, Embase, Cochrane Library were searched for the studies focused on the comparison of open and laparoscopic simultaneous surgeries for synchronous metastatic liver lesions, dated till October 20, 2020. Keywords: simultaneous resections, colorectal cancer, liver metastases, simultaneous laparoscopic.Results. Meta-analysis contains the results of 1211 simultaneous surgeries for simultaneous metastases of colorectal cancer in the liver: 450 laparoscopic and 761 open surgeries. Laparoscopic surgery was characterized with lower blood loss [weighted mean difference (WMD) = -131.77, 95% CI: -232.54 to -31.00, p = 0.01], a shorter postoperative hospitalization [WMD = -2.87, 95% CI: -3.41 to -2. 33, p < 0.00001], early first bowel movement [WMD = -0.99, 95% CI: -1.40 to -0.58, p < 0.0001], early initiation of enteral feeding [WMD = -1.20, 95% CI: -2.06 to -0.33, p = 0.007]), lower incidence of postoperative complications [OR = 0.60, 95% CI: 0.46–0.80, p = 0.0004]. A statistically significant advantage of laparoscopic access was established in overall [OR = 0.80, 95% CI: 0.64–0.99, p = 0.04] and recurrence-free survival [OR = 0.73, 95% CI: 0.60–0.89, p = 0.002].Conclusion. Perioperative and distant oncologic outcomes demonstrate safety and efficacy of laparoscopic simultaneous interventions for synchronous metastases of colorectal cancer in comparison with open interventions.
- 15 December 2022
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 27 (4) , 57-70
Open AccessComparison of laparoscopic and open simultaneous surgeries for synchronous metastases of colorectal cancer in the liver: meta-analysis
Aim. To analyze studies focused on comparing laparoscopic and open simultaneous surgeries for synchronous metastases of colorectal cancer in the liver.Materials and methods. The electronic databases PubMed, Web of Science, Scopus, Embase, Cochrane Library were searched for the studies focused on the comparison of open and laparoscopic simultaneous surgeries for synchronous metastatic liver lesions, dated till October 20, 2020. Keywords: simultaneous resections, colorectal cancer, liver metastases, simultaneous laparoscopic.Results. Meta-analysis contains the results of 1211 simultaneous surgeries for simultaneous metastases of colorectal cancer in the liver: 450 laparoscopic and 761 open surgeries. Laparoscopic surgery was characterized with lower blood loss [weighted mean difference (WMD) = -131.77, 95% CI: -232.54 to -31.00, p = 0.01], a shorter postoperative hospitalization [WMD = -2.87, 95% CI: -3.41 to -2. 33, p < 0.00001], early first bowel movement [WMD = -0.99, 95% CI: -1.40 to -0.58, p < 0.0001], early initiation of enteral feeding [WMD = -1.20, 95% CI: -2.06 to -0.33, p = 0.007]), lower incidence of postoperative complications [OR = 0.60, 95% CI: 0.46–0.80, p = 0.0004]. A statistically significant advantage of laparoscopic access was established in overall [OR = 0.80, 95% CI: 0.64–0.99, p = 0.04] and recurrence-free survival [OR = 0.73, 95% CI: 0.60–0.89, p = 0.002].Conclusion. Perioperative and distant oncologic outcomes demonstrate safety and efficacy of laparoscopic simultaneous interventions for synchronous metastases of colorectal cancer in comparison with open interventions.
- Open Access
- 15 July 2022
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 24 (2) , 216-220
Transthoracic biopsy under the control of computed tomography as a method of differential diagnosis of nodular neoplasms of the lung in outpatient settings: Retrospective cohort study
Background. Morphological verification of central and peripheral focal lung neoplasms is a difficult task for modern minimally invasive methods of differential diagnosis. The use of transthoracic trepanobiopsy of lung neoplasms under the control of computed tomography (CT) allows you to obtain informative, histological material and make a correct diagnosis. Aim. The aim of the study was to determine the possibility and safety of performing transthoracic trepanobiopsy of lung tumors under the control of CT in patients who are on an outpatient appointment in a third-level institution in order to obtain informative histological material. Materials and methods. From January 2020 to April 2021, 65 patients underwent transthoracic trepanobiopsy of focal lung neoplasms under the control of CT on an outpatient basis in the polyclinic department of the Ostroverkhov Kursk Cancer Research and Clinical Center. Results. The average time spent on performing a biopsy, with preliminary marking under CT control, was 15.14.5 minutes. In 2 (3.1%) cases, the morphological material was uninformative. The informativeness of the performed trepanobiopsies for the verification of the lung tumor process was 96.9%. Complications were observed in 5 (7.6%) patients: pneumothorax in 4 (6.1%), hemoptysis in 1 (1.5%). Pneumothorax occurred mainly in patients aged 5567 years. Conclusion. The used method of transthoracic lung trepanobiopsy under CT control should be used in outpatient settings of third-level institutions for morphological confirmation of the diagnosis, since it is safe and highly informative for patients, which is confirmed by a low percentage of complications (7.6%) and allows for differential diagnosis of focal lung neoplasms at the pre-hospital stage.
- 15 July 2022
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 24 (2) , 216-220
Open AccessTransthoracic biopsy under the control of computed tomography as a method of differential diagnosis of nodular neoplasms of the lung in outpatient settings: Retrospective cohort study
Background. Morphological verification of central and peripheral focal lung neoplasms is a difficult task for modern minimally invasive methods of differential diagnosis. The use of transthoracic trepanobiopsy of lung neoplasms under the control of computed tomography (CT) allows you to obtain informative, histological material and make a correct diagnosis. Aim. The aim of the study was to determine the possibility and safety of performing transthoracic trepanobiopsy of lung tumors under the control of CT in patients who are on an outpatient appointment in a third-level institution in order to obtain informative histological material. Materials and methods. From January 2020 to April 2021, 65 patients underwent transthoracic trepanobiopsy of focal lung neoplasms under the control of CT on an outpatient basis in the polyclinic department of the Ostroverkhov Kursk Cancer Research and Clinical Center. Results. The average time spent on performing a biopsy, with preliminary marking under CT control, was 15.14.5 minutes. In 2 (3.1%) cases, the morphological material was uninformative. The informativeness of the performed trepanobiopsies for the verification of the lung tumor process was 96.9%. Complications were observed in 5 (7.6%) patients: pneumothorax in 4 (6.1%), hemoptysis in 1 (1.5%). Pneumothorax occurred mainly in patients aged 5567 years. Conclusion. The used method of transthoracic lung trepanobiopsy under CT control should be used in outpatient settings of third-level institutions for morphological confirmation of the diagnosis, since it is safe and highly informative for patients, which is confirmed by a low percentage of complications (7.6%) and allows for differential diagnosis of focal lung neoplasms at the pre-hospital stage.
- Open Access
- 21 March 2021
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 26 (1) , 92-99
Simultaneous surgery for synchronous liver metastases of colorectal cancer: analysis of survival and negative prognosis factors
Aim. To improve the surgical treatment results among patients with synchronous liver metastasis of colorectal cancer. Materials and methods. From 2012 to 2019, the analysis of the results of treatment of 60 patients with colorectal cancer and synchronous metastatic liver disease was carried out. The study sample was divided into 2 groups of patients. The group 1 consisted of 30 patients who got simultaneous resection of liver metastases and primary colorectal cancer. The group 2 consisted of other 30 patients who got stage resections: surgery for the primary tumor at the first stage, and liver surgery for metastases at the second.Results. The median operative time was 340 ± 21.1 minutes in the group 1. In the group 2 it was 255 ± 21.1 minutes and only the liver resection stage was assessed. The median blood loss in patients of the group 1 was 520,0 [200,0;800,1] ml, in the group 2 it was 500,0 [175,0;1300,0] ml. In general, we identified 5 cases of complications. In the postoperative period, 4 patients died. The average follow-up period is 23 months. One-year survival in group 1 was 92.6%, in group 2 – 100%, three-year – 85.2% and 89.6%. One-year disease-free survival in group 1 is 70%, in group 2 – 83.3%, three-year disease-free survival – 43.3% and 36.7%.Overall and disease-free survival rates didn’t differ significantly between the two treatment strategies. We detected significant effect on the disease-free and overall survival of regional lymph nodes metastasis (both p < 0.05).Conclusion. The long-term and immediate results of simultaneous surgery of synchronous liver metastasis of colorectal cancer are comparable to the results of the staged method of treatment. It indicates the safety and effectiveness of simultaneous procedure.
- 21 March 2021
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 26 (1) , 92-99
Open AccessSimultaneous surgery for synchronous liver metastases of colorectal cancer: analysis of survival and negative prognosis factors
Aim. To improve the surgical treatment results among patients with synchronous liver metastasis of colorectal cancer. Materials and methods. From 2012 to 2019, the analysis of the results of treatment of 60 patients with colorectal cancer and synchronous metastatic liver disease was carried out. The study sample was divided into 2 groups of patients. The group 1 consisted of 30 patients who got simultaneous resection of liver metastases and primary colorectal cancer. The group 2 consisted of other 30 patients who got stage resections: surgery for the primary tumor at the first stage, and liver surgery for metastases at the second.Results. The median operative time was 340 ± 21.1 minutes in the group 1. In the group 2 it was 255 ± 21.1 minutes and only the liver resection stage was assessed. The median blood loss in patients of the group 1 was 520,0 [200,0;800,1] ml, in the group 2 it was 500,0 [175,0;1300,0] ml. In general, we identified 5 cases of complications. In the postoperative period, 4 patients died. The average follow-up period is 23 months. One-year survival in group 1 was 92.6%, in group 2 – 100%, three-year – 85.2% and 89.6%. One-year disease-free survival in group 1 is 70%, in group 2 – 83.3%, three-year disease-free survival – 43.3% and 36.7%.Overall and disease-free survival rates didn’t differ significantly between the two treatment strategies. We detected significant effect on the disease-free and overall survival of regional lymph nodes metastasis (both p < 0.05).Conclusion. The long-term and immediate results of simultaneous surgery of synchronous liver metastasis of colorectal cancer are comparable to the results of the staged method of treatment. It indicates the safety and effectiveness of simultaneous procedure.
- 1 January 2019
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 10,p. 82-87
Leiomyosarcoma of the splenic vein
Vascular leiomyosarcoma (LMS) is an extremely rare disease. Venous lesion is approximately 5 times more common than arterial. LMS is usually found in retroperitoneal veins and in inferior vena cava. Lesion of the splenic vein is extremely rare. A 52-year-old woman with recurrent abdominal pain is reported in the article. Abdominal contrast-enhanced CT revealed a 6 cm tumor of the pancreatic tail. The patient underwent laparoscopic distal pancreatectomy with splenectomy en bloc. Histological and immunohistochemical studies revealed LMS originating from the smooth muscles of the splenic vein. Surgery was followed by adjuvant chemotherapy. There was no local recurrence in 1 year after surgery. In this article, we analyze the available information on leiomyosarcoma of the splenic vein.
- 1 January 2019
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 10,p. 82-87
Leiomyosarcoma of the splenic vein
Vascular leiomyosarcoma (LMS) is an extremely rare disease. Venous lesion is approximately 5 times more common than arterial. LMS is usually found in retroperitoneal veins and in inferior vena cava. Lesion of the splenic vein is extremely rare. A 52-year-old woman with recurrent abdominal pain is reported in the article. Abdominal contrast-enhanced CT revealed a 6 cm tumor of the pancreatic tail. The patient underwent laparoscopic distal pancreatectomy with splenectomy en bloc. Histological and immunohistochemical studies revealed LMS originating from the smooth muscles of the splenic vein. Surgery was followed by adjuvant chemotherapy. There was no local recurrence in 1 year after surgery. In this article, we analyze the available information on leiomyosarcoma of the splenic vein.
- 1 January 2013
- No. 7,p. 61-2
[The posttraumatic stenosis of the lower third of the esophagus with esophageal-gastric fistulae formation].
- 1 January 2013
- No. 7,p. 61-2
[The posttraumatic stenosis of the lower third of the esophagus with esophageal-gastric fistulae formation].